AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇹🇳

CISPLATINE in Tunisia

9 products registered with DPM 0 active, 9 expired

Brand / ProductReg. No.HolderStatusExpires
CYTOCIS
Solution injectable pour perfusion / 50mg/50ml
9383072HCYTOPHARMAexpired2 Aug 2019
CYTOCIS
Solution injectable pour perfusion / 25 mg/25ml
9383071HCYTOPHARMAexpired2 Aug 2019
CYTOCIS
Solution injectable pour perfusion / 100 mg/100ml
9383073HCYTOPHARMAexpired2 Aug 2019
SINPLATIN 50 MG
Solution injectable pour perfusion / 1 mg/ml
12963042HACTAVIS SRL ROMANIAexpired23 Jul 2010
SINPLATIN
Solution injectable pour perfusion / 1 mg/ml
12963041HACTAVIS SRL ROMANIAexpired23 Jul 2010
CISPLATINE VIATRIS
Solution injectable / 25 MG
4923021HVIATRIS SANTEexpired7 Apr 2001
CISPLATIN-EBEWE
Solution injectable / 50 MG
6943043HEBEWE Pharmaexpired26 May 1998
CISPLATIN-EBEWE
Solution injectable / 10 MG
6943042HEBEWE Pharmaexpired26 May 1998
CISPLATIN-EBEWE
Solution injectable / 25 MG
6943041HEBEWE Pharmaexpired7 Sept 1995

CISPLATINEDPM Registration Details

DPM (Tunisia) has 9 registered products containing CISPLATINE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.

Track CISPLATINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Cisplatine — Tunisia (DPM) | AfricaRegulatory